Reaction

Hepatitis Fulminant reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,933 reports · 111 co-occurring drugs

As of the last recalculation, Hepatitis Fulminant appears in 2,933 FAERS reports alongside 111 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 40.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rifampicin	56	40.0	40.2
Pyrazinamide	49	37.6	37.8
Isoniazid	50	22.3	22.3
Acetylcysteine	20	15.2	15.2
Sevoflurane	17	14.6	14.6
Desloratadine	20	13.3	13.3
Meropenem	57	12.8	12.9
Lopinavir And Ritonavir	24	12.7	12.7
Daspone	17	12.5	12.5
Dapsone Gel, 5%	17	12.4	12.5
Dapsone	17	11.4	11.4
Piperacillin And Tazobactam	20	11.2	11.2
Lamivudine	47	11.0	11.0
Raltegravir	25	10.8	10.8
Dolutegravir Sodium	13	10.3	10.3
Midazolam Hydrochloride	36	9.6	9.6
Lamivudine Oral	33	9.4	9.4
Piperacillin Sodium,Tazobactam Sodium	34	9.2	9.2
Piperacillin Sodium And Tazobactam Sodium	25	9.1	9.1
Oseltamivir Phosphate	31	9.1	9.1
Tenofovir Disoproxil Fumarate Tablets	11	9.1	9.1
Ceftriaxone Sodium	48	9.0	9.0
Clarithromycin	43	9.0	9.0
Acetaminophen Tablet Extended Release	293	8.9	9.0
Pain Reliever	293	8.9	9.0
Acetaminophen 500Mg	293	8.9	8.9
Imatinib	22	8.9	8.9
Bicalutamide	19	8.9	8.9
Propofol	45	8.9	8.9
Abacavir Sulfate	12	8.8	8.8
Linezolid	35	8.4	8.4
Midazolam	29	8.2	8.2
Amoxicillin And Clavulanate Potassium	31	8.2	8.2
Ketoprofen	15	8.2	8.2
Entecavir	13	7.9	7.9
Ceftriaxone	36	7.9	7.9
Rifampin	16	7.8	7.8
Emtricitabine And Tenofovir Disoproxil Fumarate	49	7.7	7.7
Posaconazole	17	7.5	7.5
Misoprostol	10	7.3	7.3
Crizotinib	13	7.3	7.3
Valproate Sodium	21	7.3	7.3
Heparin Sodium	14	7.3	7.3
Efavirenz	11	7.0	7.0
Amiodarone Hydrochloride	11	7.0	7.0
Sulfamethoxazole And Trimethoprim	80	6.9	6.9
Ursodiol	21	6.9	6.9
Tolvaptan	14	6.9	6.9
Regorafenib	11	6.7	6.8
Thiotepa	9	6.7	6.7
Amikacin	16	6.7	6.7
Melphalan	21	6.6	6.6
Norepinephrine Bitartrate	13	6.4	6.4
Remdesivir	12	6.4	6.4
Nevirapine	8	6.3	6.3
Melphalan Hydrochloride	22	6.3	6.3
Ketoconazole Foam	13	6.3	6.3
Ketoconazole Cream, 2%	13	6.2	6.2
Rabeprazole	19	6.1	6.1
Norepinephrine	9	6.0	6.0
Cefazolin Sodium	10	5.9	5.9
Phenobarbital	12	5.9	5.9
Zidovudine	11	5.9	5.9
Phenytoin	17	5.8	5.8
Tenofovir Disoproxil Fumarate	26	5.6	5.6
Brentuximab Vedotin	8	5.6	5.6
Ipilimumab	33	5.5	5.5
Ketoconazole	13	5.3	5.4
Nivolumab	71	5.3	5.3
Magnesium Oxide	31	5.3	5.3
Enoxaparin Sodium	41	5.1	5.1
Hydroxyurea	15	5.1	5.1
Voriconazole	21	4.9	4.9
Paroxetine Hydrochloride Hemihydrate	23	4.9	4.9
Dexamethasone Sodium Phosphate	7	4.9	4.9
Paroxetine	23	4.8	4.8
Rabeprazole Sodium	18	4.7	4.7
Sorafenib	13	4.5	4.5
Eplerenone	8	4.4	4.4
Pembrolizumab	63	4.3	4.3
Febuxostat Tablets 40 Mg	6	4.2	4.2
Febuxostat Tablets 80 Mg	6	4.2	4.2
Pitavastatin Calcium	6	4.2	4.2
Abiraterone Acetate	24	4.2	4.2
Bleomycin Sulfate	6	4.1	4.1
Cytarabine	34	4.1	4.1
Pazopanib Hydrochloride	15	3.9	4.0
Gefitinib	5	3.9	3.9
Cyclophosphamide Injection, Solution	94	3.9	3.9
Cyclophosphamide	94	3.9	3.9
Cyclophosphamide For Injection	94	3.9	3.9
Etoposide	39	3.8	3.8
Rocuronium Bromide	6	3.6	3.6
Busulfan	8	3.6	3.6
Doxorubicin	43	3.5	3.5
Sunitinib Malate	19	3.4	3.4
Paclitaxel (Aibumin-Bound)	38	3.3	3.3
Doxorubicin Hydrochloride	15	3.3	3.3
Abiraterone	6	3.1	3.1
Paclitaxel	42	3.0	3.0
Bendamustine Hydrochloride	5	3.0	3.0
Cisplatin	31	2.8	2.8
Atezolizumab	15	2.8	2.8
Iohexol	3	2.6	2.6
Gemcitabine Hydrochloride	19	2.6	2.6
Dasatinib	13	2.5	2.5
Orlistat	8	2.2	2.2
Obinutuzumab	5	2.2	2.2
Durvalumab	5	1.7	1.7
Ledipasvir And Sofosbuvir	4	1.5	1.5
Nirmatrelvir And Ritonavir	7	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.